首頁 > 市場調查報告書 > 製藥

疼痛

市場調查報告書

商品編碼

1698104

慢性疼痛治療市場－全球產業規模、佔有率、趨勢、機會和預測，按適應症、產品類型、配銷通路、地區和競爭細分，2020-2030 年

Chronic Pain Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication, By Product Type, By Distribution Channel, By Region and Competition, 2020-2030F

出版日期: 2025年03月28日 | 出版商:

TechSci Research | 英文 186 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024 年全球慢性疼痛治療市場價值為 842.3 億美元，預計到 2030 年將達到 1,320.8 億美元，複合年成長率為 7.76%。全球慢性疼痛治療市場正在大幅擴張，這得益於越來越多的人患有長期疼痛疾病，如關節炎、神經病變、纖維肌痛和下背痛。老齡人口的增加對市場成長做出了巨大貢獻，因為老年人更容易因退化性疾病和肌肉骨骼疾病而出現慢性疼痛。醫學研究的進步促進了更有效的疼痛管理解決方案的開發，包括非鴉片類鎮痛藥和生物製劑等藥物干預以及神經刺激和再生醫學等非藥物治療。提高患者對可用治療方案的認知以及個人化醫療在疼痛管理中的整合正在促進創新療法的採用。各國不斷成長的醫療支出和改善的報銷政策進一步支持了市場擴張，使患者更容易獲得先進的慢性疼痛治療。

市場概覽
預測期	2026-2030
2024年市場規模	842.3億美元
2030年市場規模	1320.8億美元
2025-2030 年複合年成長率	7.76％
成長最快的領域	神經性疼痛
最大的市場	北美洲

對更安全、更有效的疼痛管理策略的需求正在塑造主要的市場趨勢，由於對鴉片類藥物成癮和依賴性的擔憂，非鴉片類藥物療法明顯轉向。神經調節技術（包括脊髓刺激和經皮神經電刺激 (TENS)）的出現透過提供有針對性的微創解決方案徹底改變了慢性疼痛治療。再生醫學，包括幹細胞療法和富血小板血漿 (PRP) 注射，作為長期緩解疼痛和修復組織的一種有希望的替代療法，正受到越來越多的關注。行動應用程式和穿戴式裝置等數位健康解決方案透過實現遠端監控、患者參與和數據驅動的治療計劃來改善疼痛管理。人們越來越關注多學科疼痛管理方法，這種方法結合了藥物治療、介入治療和心理治療，有助於改善患者的治療效果並推動市場成長。

關鍵市場促進因素

人口老化加劇

主要市場挑戰

鴉片類藥物危機與監管審查

主要市場趨勢

非鴉片類疼痛治療的興起

由於擔心鴉片類藥物相關的副作用和成癮性，患者擴大尋求非鴉片類藥物治療，從而產生了對替代性疼痛管理解決方案的需求。

Global Chronic Pain Treatment Market was valued at USD 84.23 Billion in 2024 and is expected to reach USD 132.08 Billion in the forecast period with a CAGR of 7.76% through 2030. The global chronic pain treatment market is experiencing substantial expansion, driven by an increasing number of individuals suffering from long-term pain conditions such as arthritis, neuropathy, fibromyalgia, and lower back pain. The rising aging population contributes significantly to market growth, as elderly individuals are more prone to chronic pain due to degenerative diseases and musculoskeletal disorders. Advances in medical research have led to the development of more effective pain management solutions, ranging from pharmaceutical interventions like non-opioid analgesics and biologics to non-pharmacological treatments such as neurostimulation and regenerative medicine. Increasing patient awareness regarding available treatment options and the integration of personalized medicine in pain management are enhancing the adoption of innovative therapies. Growing healthcare expenditure and improved reimbursement policies in various countries further support market expansion, allowing patients greater access to advanced chronic pain treatments.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 84.23 Billion
Market Size 2030	USD 132.08 Billion
CAGR 2025-2030	7.76%
Fastest Growing Segment	Neuropathic Pain
Largest Market	North America

The demand for safer and more effective pain management strategies is shaping key market trends, with a notable shift toward non-opioid therapies due to concerns over opioid addiction and dependency. The emergence of neuromodulation technologies, including spinal cord stimulation and transcutaneous electrical nerve stimulation (TENS), is revolutionizing chronic pain treatment by offering targeted and minimally invasive solutions. Regenerative medicine, including stem cell therapy and platelet-rich plasma (PRP) injections, is gaining traction as a promising alternative for long-term pain relief and tissue repair. Digital health solutions, such as mobile applications and wearable devices, are improving pain management by enabling remote monitoring, patient engagement, and data-driven treatment plans. The increasing focus on multidisciplinary pain management approaches, which combine pharmacological, interventional, and psychological therapies, is contributing to better patient outcomes and driving market growth.

Key Market Drivers

Increasing Aging Population

The increasing aging population is a pivotal driver for the Global Chronic Pain Treatment Market, impacting the healthcare industry in several profound ways. With age comes an increased susceptibility to chronic pain conditions such as osteoarthritis, rheumatoid arthritis, neuropathy, and musculoskeletal disorders. In 2022, the age-adjusted prevalence of diagnosed arthritis in U.S. adults was 18.9%, with the percentage rising significantly with age from 3.6% in adults aged 18-34 to 53.9% in those aged 75 and older. This heightened prevalence among the elderly directly fuels the demand for effective pain management solutions.

Advances in healthcare have resulted in extended life expectancy worldwide. For instance, in 2023, life expectancy at birth for the U.S. population increased to 78.4 years, up from 77.5 years in 2022. While this is a remarkable achievement, it also means that a significant portion of the population is living longer, thereby increasing the likelihood of experiencing chronic pain as they age. Elderly individuals commonly suffer from multiple chronic health conditions simultaneously, which can exacerbate pain symptoms and necessitate more complex and comprehensive pain management strategies.

Key Market Challenges

Opioid Crisis and Regulatory Scrutiny

The opioid crisis, characterized by the misuse and addiction to prescription opioid pain relievers, has led to heightened regulatory scrutiny on the use of opioids in chronic pain management. In response to the crisis, regulators have imposed stricter guidelines on opioid prescribing, distribution, and monitoring.

Stricter regulations have made it more challenging for patients to access opioid-based pain medications, even when medically necessary, leading to concerns about undertreated pain. Healthcare providers and pharmaceutical companies face increased legal liability related to opioid prescriptions, which can result in cautious prescribing practices and a reluctance to develop new opioid-based pain medications.

Key Market Trends

Rise in Non-Opioid Pain Management

Trend: There is a growing shift away from opioid-based pain management towards non-opioid alternatives. This trend is driven by concerns over the opioid crisis, regulatory restrictions on opioid prescriptions, and the desire to reduce the risk of addiction and overdose.

Opioid medications carry a risk of addiction and overdose, making non-opioid alternatives more attractive for patients and healthcare providers concerned about patient safety. Stricter regulations on opioid prescribing and dispensing have pushed healthcare providers to explore non-opioid treatments to comply with these guidelines.

Patients are increasingly seeking non-opioid options due to the fear of opioid-related side effects and addiction, creating a demand for alternative pain management solutions.

Key Market Players

Pfizer Inc

Abbott Laboratories

Eli Lilly and Company

Novartis AG

Johnson & Johnson

Sanofi SA

Teva Pharmaceutical Industries Ltd

Baxter International

Merck & Co. Inc

Boston Scientific Corporation

Report Scope:

In this report, the Global Chronic Pain Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Chronic Pain Treatment Market, By Indication:

Neuropathic Pain
Analgesic Infusion
Ablation

Chronic Pain Treatment Market, By Product Type:

Drugs
Devices

Chronic Pain Treatment Market, By Distribution Channel:

Hospital & Clinics
Ambulatory Centers
Others

Chronic Pain Treatment Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Chronic Pain Treatment Market.

Available Customizations:

Global Chronic Pain Treatment market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Chronic Pain Treatment Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Indication (Neuropathic Pain, Analgesic Infusion, Ablation)
- 5.2.2. By Product Type (Drugs, Devices)
- 5.2.3. By Distribution Channel (Hospital & Clinics, Ambulatory Centers, Others)
- 5.2.4. By Region
- 5.2.5. By Company (2024)
5.3. Market Map

6. North America Chronic Pain Treatment Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Indication
- 6.2.2. By Product Type
- 6.2.3. By Distribution Channel
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Chronic Pain Treatment Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Indication
    - 6.3.1.2.2. By Product Type
    - 6.3.1.2.3. By Distribution Channel
- 6.3.2. Canada Chronic Pain Treatment Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Indication
    - 6.3.2.2.2. By Product Type
    - 6.3.2.2.3. By Distribution Channel
- 6.3.3. Mexico Chronic Pain Treatment Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Indication
    - 6.3.3.2.2. By Product Type
    - 6.3.3.2.3. By Distribution Channel

7. Europe Chronic Pain Treatment Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Indication
- 7.2.2. By Product Type
- 7.2.3. By Distribution Channel
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Chronic Pain Treatment Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Indication
    - 7.3.1.2.2. By Product Type
    - 7.3.1.2.3. By Distribution Channel
- 7.3.2. United Kingdom Chronic Pain Treatment Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Indication
    - 7.3.2.2.2. By Product Type
    - 7.3.2.2.3. By Distribution Channel
- 7.3.3. Italy Chronic Pain Treatment Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Indication
    - 7.3.3.2.2. By Product Type
    - 7.3.3.2.3. By Distribution Channel
- 7.3.4. France Chronic Pain Treatment Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Indication
    - 7.3.4.2.2. By Product Type
    - 7.3.4.2.3. By Distribution Channel
- 7.3.5. Spain Chronic Pain Treatment Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Indication
    - 7.3.5.2.2. By Product Type
    - 7.3.5.2.3. By Distribution Channel

8. Asia-Pacific Chronic Pain Treatment Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Indication
- 8.2.2. By Product Type
- 8.2.3. By Distribution Channel
- 8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Chronic Pain Treatment Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Indication
    - 8.3.1.2.2. By Product Type
    - 8.3.1.2.3. By Distribution Channel
- 8.3.2. India Chronic Pain Treatment Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Indication
    - 8.3.2.2.2. By Product Type
    - 8.3.2.2.3. By Distribution Channel
- 8.3.3. Japan Chronic Pain Treatment Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Indication
    - 8.3.3.2.2. By Product Type
    - 8.3.3.2.3. By Distribution Channel
- 8.3.4. South Korea Chronic Pain Treatment Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Indication
    - 8.3.4.2.2. By Product Type
    - 8.3.4.2.3. By Distribution Channel
- 8.3.5. Australia Chronic Pain Treatment Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Indication
    - 8.3.5.2.2. By Product Type
    - 8.3.5.2.3. By Distribution Channel

9. South America Chronic Pain Treatment Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Indication
- 9.2.2. By Product Type
- 9.2.3. By Distribution Channel
- 9.2.4. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Chronic Pain Treatment Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Indication
    - 9.3.1.2.2. By Product Type
    - 9.3.1.2.3. By Distribution Channel
- 9.3.2. Argentina Chronic Pain Treatment Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Indication
    - 9.3.2.2.2. By Product Type
    - 9.3.2.2.3. By Distribution Channel
- 9.3.3. Colombia Chronic Pain Treatment Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Indication
    - 9.3.3.2.2. By Product Type
    - 9.3.3.2.3. By Distribution Channel

10. Middle East and Africa Chronic Pain Treatment Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Indication
- 10.2.2. By Product Type
- 10.2.3. By Distribution Channel
- 10.2.4. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Chronic Pain Treatment Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Indication
    - 10.3.1.2.2. By Product Type
    - 10.3.1.2.3. By Distribution Channel
- 10.3.2. Saudi Arabia Chronic Pain Treatment Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Indication
    - 10.3.2.2.2. By Product Type
    - 10.3.2.2.3. By Distribution Channel
- 10.3.3. UAE Chronic Pain Treatment Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Indication
    - 10.3.3.2.2. By Product Type
    - 10.3.3.2.3. By Distribution Channel